SPARQ: An Accelerator Architecture for Large Language Models with Joint Sparsity and Quantization Techniques [PDF]
Sung Ho Choi, Hyungmin Cho
openalex +1 more source
Retractions in rheumatology: trends, causes, and implications for research integrity
Objective We aimed to describe the trends and main reasons for study retraction in rheumatology literature. Methods We reviewed the Retraction Watch database to identify retracted articles in rheumatology. We recorded the main study characteristics, authors’ countries, reasons for retraction, time from publication to retraction, and trends over time ...
Anna Maria Vettori, Michele Iudici
wiley +1 more source
Development and validation of the manual disease activity score (MDAS) for rheumatoid arthritis. [PDF]
Salim B +9 more
europepmc +1 more source
OTPTO: Joint Product Selection and Inventory Optimization in Fresh E-commerce Front-End Warehouses [PDF]
Zheming Zhang +3 more
openalex +1 more source
Full-range behavior of FRP-to-concrete bonded joints
Hong Yuan +4 more
semanticscholar +1 more source
New Onset of Fibromyalgia After Exposure to a Combat Environment: A Longitudinal Cohort Study
Objective Traumatic life events are hypothesized to be triggers for the onset of fibromyalgia. Posttraumatic stress disorder (PTSD) is a common comorbidity of fibromyalgia. However, limited prospective data are available on the development of fibromyalgia after exposure to high magnitude stress.
Jay B. Higgs +15 more
wiley +1 more source
Very Low Preoperative Grip Strength Associated With Poor Pyrocarbon Metacarpophalangeal Implant Survivorship in Rheumatoid Arthritis. [PDF]
Schluttenhofer A +4 more
europepmc +1 more source
Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures.
V. Mow, A. Ratcliffe, Poole Ar
semanticscholar +1 more source
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie +3 more
wiley +1 more source

